Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Genetics in Medicine
  • View all journals
  • Search
  • Log in
  • Content Explore content
  • RSS feed
  1. nature
  2. genetics in medicine
  3. abstracts
  4. article
The relationship between the Glu298Asp and intron 4 polymorphisms of endothelial nitric oxide synthase in an Hispanic population with preeclampsia
Download PDF
Download PDF
  • Abstracts
  • Published: 01 January 2000

Abstract

The relationship between the Glu298Asp and intron 4 polymorphisms of endothelial nitric oxide synthase in an Hispanic population with preeclampsia

  • A Pellicena1,
  • S Riskin-Mashiah1,
  • L A Hefler1 &
  • …
  • A R Gregg1,2 

Genetics in Medicine volume 2, page 112 (2000)Cite this article

  • 250 Accesses

  • Metrics details

Abstract

Endothelial nitric oxide synthase (eNOS) enzymatically converts L-arginine to L-citrulline within endothelial cells. This reaction results in the release of nitric oxide (NO). NO mediates vascular smooth muscle relaxation and has been proposed to be an important regulator of blood pressure homoeostasis during pregnancy. Our laboratory previously demonstrated an association between preeclampsia and a polymorphism (27 bp repeat) within intron 4 (I-4) of the eNOS gene (NOS3). We sought to establish whether a missense mutation (Glu298Asp) within exon 7 (E-7) of NOS3 co-segregates with the I-4 polymorphism. We also studied the combined effect of the NOS3 I-4 polymorphism and NOS3 E-7 mutation on clinical phenotype.

Methods: Genomic DNA was extracted from blood of 54 women with preeclampsia (PET) and 37 controls. Genotyping was performed by PCR (I-4) and PCR-RFLP analysis (E-7). Women with at least one NOS3 I-4 copy allele were designated A and those with the more common 5 copy were scored B. Women with at least one E-7 mutation were designated M and those with no mutation were designated N. All products were scored using a 1.5% agarose gel.

Results: One of 5 women homozygous for the I-4 A-allele also had an E-7 mutation. None of the four women homozygous for the E-7 mutation had the I-4 A-allele. All women homozygous for the E-7 mutation were identified within the control group. Among women with PET, those scored as B/M had significantly higher blood urea nitrogen (18.6 mg/dl) when compared to those scored as B/N (9.8 mg/dl), A/N (10.6 mg/dl), and A/M (10.5 mg/dl). Women with a B/M score also had a significantly greater urine dip-stick protein value (median 3 vs. 2.5) and higher weight on admission (201 vs. 164 Ibs) than women scored as B/N.

Conclusion: The I-4 polymorphism and the E-7 mutation in NOS3 do not appear to co-segregate. The E-7 mutation of NOS3 may have specific influences on the phenotypic features observed among women with preeclampsia.

Article PDF

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, 77030, Texas

    A Pellicena, S Riskin-Mashiah, L A Hefler & A R Gregg

  2. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, 77030, Texas

    A R Gregg

Authors
  1. A Pellicena
    View author publications

    Search author on:PubMed Google Scholar

  2. S Riskin-Mashiah
    View author publications

    Search author on:PubMed Google Scholar

  3. L A Hefler
    View author publications

    Search author on:PubMed Google Scholar

  4. A R Gregg
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pellicena, A., Riskin-Mashiah, S., Hefler, L. et al. The relationship between the Glu298Asp and intron 4 polymorphisms of endothelial nitric oxide synthase in an Hispanic population with preeclampsia. Genet Med 2, 112 (2000). https://doi.org/10.1097/00125817-200001000-00223

Download citation

  • Issue date: 01 January 2000

  • DOI: https://doi.org/10.1097/00125817-200001000-00223

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Genetics in Medicine (Genet Med)

ISSN 1530-0366 (online)

ISSN 1098-3600 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited